Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Mayumi Nakagawa

Concepts (243)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Papillomavirus Infections
15
2024
177
4.190
Why?
Human papillomavirus 16
11
2021
44
3.310
Why?
Uterine Cervical Neoplasms
10
2024
301
3.080
Why?
Papillomavirus Vaccines
7
2021
74
3.000
Why?
Oncogene Proteins, Viral
11
2011
52
2.250
Why?
Papillomaviridae
7
2019
104
2.130
Why?
Repressor Proteins
9
2011
149
1.950
Why?
Epitopes, T-Lymphocyte
7
2018
25
1.740
Why?
Cancer Vaccines
3
2021
79
1.470
Why?
T-Lymphocytes
6
2021
320
1.320
Why?
Candida
4
2018
63
1.230
Why?
CD8-Positive T-Lymphocytes
6
2018
145
1.190
Why?
Cervix Uteri
3
2021
43
0.810
Why?
Uterine Cervical Dysplasia
2
2015
51
0.760
Why?
Immunity, Cellular
4
2013
64
0.670
Why?
Lymphocytes, Tumor-Infiltrating
1
2021
89
0.660
Why?
Epitopes
2
2015
61
0.650
Why?
Langerhans Cells
3
2018
11
0.640
Why?
Neoplasms
2
2021
1335
0.620
Why?
Viral Load
2
2019
83
0.600
Why?
Health Education
1
2021
159
0.590
Why?
Cell Cycle Checkpoints
1
2019
32
0.590
Why?
HLA Antigens
4
2006
55
0.560
Why?
Humans
44
2026
53246
0.550
Why?
Female
30
2026
28792
0.520
Why?
Adult
21
2025
14541
0.520
Why?
CD4-Positive T-Lymphocytes
3
2018
166
0.520
Why?
Colorectal Neoplasms
1
2021
302
0.520
Why?
Health Knowledge, Attitudes, Practice
1
2021
523
0.490
Why?
Plasma Exchange
2
2014
25
0.470
Why?
Cross Protection
1
2015
5
0.450
Why?
T-Lymphocytes, Regulatory
2
2016
83
0.450
Why?
Colposcopy
1
2015
17
0.440
Why?
Interleukin-12
2
2018
26
0.430
Why?
Adjuvants, Immunologic
2
2018
52
0.430
Why?
Immunity, Innate
1
2015
112
0.420
Why?
Interferon-gamma
2
2012
174
0.410
Why?
Health
1
2013
21
0.400
Why?
Lectins, C-Type
1
2013
30
0.400
Why?
Papillomavirus E7 Proteins
8
2018
30
0.400
Why?
Middle Aged
15
2025
13422
0.400
Why?
Young Adult
9
2021
4514
0.390
Why?
Patient Selection
1
2015
273
0.380
Why?
Afibrinogenemia
1
2012
5
0.370
Why?
Enzyme-Linked Immunospot Assay
1
2012
3
0.360
Why?
Breast Neoplasms
1
2021
1223
0.360
Why?
T-Lymphocytes, Cytotoxic
4
2009
67
0.360
Why?
Cell Proliferation
5
2021
1031
0.340
Why?
Vaginal Smears
3
2021
28
0.330
Why?
Warts
1
2010
14
0.330
Why?
Plateletpheresis
1
2010
7
0.330
Why?
Antigens, Fungal
1
2010
20
0.320
Why?
Early Detection of Cancer
3
2021
190
0.320
Why?
Blood Preservation
1
2010
27
0.320
Why?
Dermatitis
1
2010
36
0.320
Why?
Blood Proteins
1
2010
84
0.310
Why?
Anaphylaxis
1
2010
69
0.310
Why?
Cells, Cultured
5
2021
1569
0.300
Why?
Antigens, Viral
2
2009
44
0.280
Why?
Immunotherapy
1
2010
266
0.280
Why?
Telemedicine
1
2015
512
0.280
Why?
Blood Platelets
1
2010
247
0.280
Why?
Human papillomavirus 18
1
2008
9
0.280
Why?
Host-Pathogen Interactions
2
2021
135
0.260
Why?
Hematopoietic Stem Cell Transplantation
2
2025
610
0.260
Why?
Dendritic Cells
1
2008
133
0.260
Why?
Vaccinia virus
1
2007
6
0.250
Why?
Immunoenzyme Techniques
1
2007
134
0.250
Why?
Immunophenotyping
1
2007
118
0.250
Why?
Neoplasm Staging
2
2025
774
0.240
Why?
Glomerulonephritis, IGA
1
2026
6
0.240
Why?
Methylprednisolone
1
2026
41
0.230
Why?
Proteinuria
1
2026
38
0.230
Why?
Aged
10
2025
10430
0.230
Why?
Tonsillectomy
1
2026
50
0.230
Why?
Remission Induction
2
2026
222
0.220
Why?
Blood Component Removal
1
2025
17
0.220
Why?
Cell Line, Tumor
5
2021
1470
0.220
Why?
Adolescent
6
2026
6912
0.220
Why?
Isoantibodies
1
2004
26
0.210
Why?
Neoplasm Grading
2
2021
128
0.210
Why?
Lead
1
2004
33
0.210
Why?
Neutropenia
1
2004
113
0.210
Why?
Infant, Very Low Birth Weight
1
2004
58
0.210
Why?
Endometrial Neoplasms
1
2025
143
0.210
Why?
Treatment Outcome
4
2026
5597
0.200
Why?
Glucocorticoids
1
2026
236
0.200
Why?
DNA, Viral
3
2011
136
0.200
Why?
Oropharyngeal Neoplasms
1
2024
19
0.200
Why?
Anus Neoplasms
1
2024
26
0.200
Why?
Hematopoietic Stem Cells
1
2025
189
0.200
Why?
Blood Transfusion
1
2004
127
0.200
Why?
Coinfection
1
2024
41
0.200
Why?
Penile Neoplasms
1
2024
45
0.190
Why?
High-Throughput Nucleotide Sequencing
2
2021
181
0.190
Why?
Antibody Formation
1
2002
49
0.180
Why?
Capsid Proteins
1
2002
24
0.180
Why?
Practice Guidelines as Topic
1
2025
502
0.180
Why?
Clone Cells
3
2007
76
0.180
Why?
Genes, T-Cell Receptor
1
2021
5
0.180
Why?
Cytokines
2
2016
627
0.180
Why?
Clinical Trials, Phase I as Topic
1
2021
24
0.170
Why?
Time Factors
3
2026
2992
0.170
Why?
Pilot Projects
2
2021
727
0.170
Why?
Mass Screening
2
2021
362
0.170
Why?
Cystadenocarcinoma, Serous
1
2021
73
0.170
Why?
Lymphocyte Activation
1
2021
163
0.170
Why?
Videotape Recording
1
2021
26
0.160
Why?
Left-Right Determination Factors
1
2020
1
0.160
Why?
Nodal Protein
1
2020
3
0.160
Why?
Amino Acid Sequence
3
2008
563
0.160
Why?
Male
11
2026
27444
0.160
Why?
Mammography
1
2021
99
0.160
Why?
Focus Groups
1
2021
204
0.150
Why?
Multiple Myeloma
2
2025
3082
0.150
Why?
Enzyme-Linked Immunosorbent Assay
3
2010
233
0.150
Why?
Metagenome
1
2019
40
0.150
Why?
Dose-Response Relationship, Drug
2
2016
1367
0.150
Why?
Retrospective Studies
6
2026
6821
0.150
Why?
Feasibility Studies
1
2021
412
0.140
Why?
Glioblastoma
1
2020
101
0.140
Why?
Parenteral Nutrition
1
2019
29
0.140
Why?
Up-Regulation
1
2020
456
0.140
Why?
Health Behavior
1
2021
261
0.140
Why?
Transplantation Conditioning
1
2019
96
0.140
Why?
DNA
1
2021
535
0.140
Why?
Bacteria
1
2019
226
0.130
Why?
Leukocytes, Mononuclear
2
2016
122
0.130
Why?
HLA-B Antigens
2
2008
8
0.130
Why?
Age Factors
1
2021
1136
0.130
Why?
Cell Line
2
2012
1016
0.130
Why?
Ovarian Neoplasms
1
2021
459
0.130
Why?
Brain Neoplasms
1
2020
319
0.120
Why?
Histocompatibility Antigens Class II
2
2008
35
0.120
Why?
Head and Neck Neoplasms
1
2019
292
0.120
Why?
Vaccines, Subunit
1
2016
15
0.120
Why?
Body Mass Index
1
2019
717
0.110
Why?
Molecular Sequence Data
2
2008
759
0.110
Why?
Adaptive Immunity
1
2015
32
0.110
Why?
Chromatography, Liquid
1
2016
245
0.110
Why?
Leukocyte Count
2
2004
71
0.110
Why?
Peptides
2
2006
234
0.110
Why?
Tandem Mass Spectrometry
1
2016
255
0.110
Why?
Factor VIII
1
2014
24
0.110
Why?
ADAM Proteins
1
2014
21
0.100
Why?
Purpura, Thrombotic Thrombocytopenic
1
2014
16
0.100
Why?
Proteome
1
2016
178
0.100
Why?
Antigens, CD1
1
2013
9
0.100
Why?
Mannose-Binding Lectins
1
2013
7
0.100
Why?
Receptors, Pattern Recognition
1
2013
4
0.100
Why?
Indicators and Reagents
1
2013
36
0.100
Why?
Intracellular Space
1
2013
24
0.100
Why?
Skin Tests
1
2013
60
0.100
Why?
Vaccination
1
2016
310
0.100
Why?
Cadherins
1
2013
62
0.100
Why?
Proteomics
1
2016
337
0.100
Why?
Communication
1
2015
263
0.090
Why?
Antigens, CD
1
2013
217
0.090
Why?
Research Design
1
2015
373
0.090
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2013
579
0.090
Why?
Rural Health Services
1
2015
179
0.090
Why?
Socioeconomic Factors
1
2015
623
0.090
Why?
Recurrence
2
2026
694
0.090
Why?
Longitudinal Studies
2
2005
774
0.080
Why?
Injections, Intralesional
1
2010
32
0.080
Why?
Isotonic Solutions
1
2010
19
0.080
Why?
Platelet Transfusion
1
2010
33
0.080
Why?
P-Selectin
1
2010
27
0.080
Why?
Sodium Chloride
1
2010
53
0.080
Why?
Platelet Aggregation
1
2010
77
0.080
Why?
Platelet Activation
1
2010
48
0.080
Why?
Hypersensitivity
1
2010
83
0.080
Why?
Japan
2
2025
42
0.070
Why?
Polymerase Chain Reaction
1
2010
452
0.070
Why?
Complement Factor I
1
2008
2
0.070
Why?
HLA-A Antigens
1
2008
11
0.070
Why?
Haplotypes
1
2008
96
0.070
Why?
Antigen Presentation
1
2008
25
0.070
Why?
Immunologic Memory
1
2008
31
0.070
Why?
Prognosis
2
2025
2118
0.070
Why?
Histocompatibility Antigens Class I
1
2008
47
0.070
Why?
Signal Transduction
2
2020
1748
0.070
Why?
Animals
2
2019
13528
0.060
Why?
DNA, Recombinant
1
2007
15
0.060
Why?
Genes, MHC Class I
1
2006
11
0.060
Why?
Arkansas
1
2013
2068
0.060
Why?
Binding, Competitive
1
2006
89
0.060
Why?
Pulse Therapy, Drug
1
2026
5
0.060
Why?
Polymorphism, Single Nucleotide
1
2008
505
0.060
Why?
Leukapheresis
1
2025
19
0.060
Why?
Antigens, CD34
1
2025
76
0.060
Why?
Calgranulin B
1
2005
4
0.060
Why?
Calgranulin A
1
2005
5
0.050
Why?
Cryopreservation
1
2025
41
0.050
Why?
Epitope Mapping
1
2004
6
0.050
Why?
Immunomagnetic Separation
1
2004
8
0.050
Why?
Societies, Medical
1
2025
207
0.050
Why?
Risk Factors
1
2013
4018
0.050
Why?
Transplantation, Autologous
1
2025
488
0.050
Why?
Phosphorylation
2
2020
533
0.050
Why?
Sensitivity and Specificity
1
2005
869
0.050
Why?
Mutation
1
2008
1338
0.050
Why?
Tumor Virus Infections
1
2002
46
0.050
Why?
Antibodies, Viral
1
2002
109
0.040
Why?
Lactobacillus
1
2021
5
0.040
Why?
Immunoglobulin G
1
2002
192
0.040
Why?
SOX Transcription Factors
1
2021
5
0.040
Why?
Cytodiagnosis
1
2021
42
0.040
Why?
Neuroendocrine Cells
1
2021
9
0.040
Why?
Biological Specimen Banks
1
2021
22
0.040
Why?
Neoplasm Recurrence, Local
1
2025
647
0.040
Why?
Cytoplasm
1
2021
93
0.040
Why?
Cobalt
1
2020
16
0.040
Why?
Neoplastic Stem Cells
1
2021
90
0.040
Why?
Cohort Studies
1
2004
1557
0.040
Why?
Cell Hypoxia
1
2020
82
0.040
Why?
Vulnerable Populations
1
2020
54
0.040
Why?
Epithelial-Mesenchymal Transition
1
2020
56
0.040
Why?
Cell Movement
1
2021
279
0.040
Why?
Multivariate Analysis
1
2021
598
0.040
Why?
Community Health Workers
1
2020
62
0.040
Why?
Parenteral Nutrition, Total
1
2019
28
0.040
Why?
Cell Survival
1
2020
600
0.040
Why?
Sequence Analysis, DNA
1
2019
216
0.040
Why?
Cell Differentiation
1
2021
681
0.030
Why?
Phenotype
1
2021
803
0.030
Why?
Models, Biological
1
2021
737
0.030
Why?
Linear Models
1
2019
287
0.030
Why?
Immunity, Humoral
1
2018
23
0.030
Why?
Aged, 80 and over
1
2025
3495
0.030
Why?
Child, Preschool
1
2026
4164
0.030
Why?
Infant, Newborn
1
2004
2913
0.030
Why?
Gene Expression Regulation, Neoplastic
1
2020
868
0.030
Why?
Autoantibodies
1
2014
120
0.020
Why?
Child
1
2026
7384
0.020
Why?
Mice, Inbred C57BL
1
2018
1925
0.020
Why?
Immunosuppressive Agents
1
2014
253
0.020
Why?
Combined Modality Therapy
1
2014
640
0.020
Why?
Genetics, Population
1
2008
12
0.020
Why?
Alleles
1
2008
277
0.020
Why?
Mice
1
2018
5982
0.020
Why?
Casein Kinase II
1
2005
9
0.010
Why?
Cell Division
1
2005
289
0.010
Why?
Nakagawa's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description